StonvexLoading…
StonvexStonvexStonvexCore line items from ITP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $75.84M | $86.55M | $100.35M | $160.88M |
Operating Income | $-8.21M | $-9.58M | $-5.30M | $1.46M |
Net Income | $-9.84M | $-9.95M | $-16.57M | $905.53K |
EPS (Diluted) | $-0.98 | $-0.99 | $-1.66 | $0.10 |
Total Assets | $177.55M | $194.74M | $204.45M | $241.54M |
Total Liabilities | $21.50M | $26.41M | $23.12M | $25.79M |
Cash & Equivalents | $6.95M | $4.39M | $9.52M | $11.20M |
Free Cash Flow OCF − CapEx | $5.97M | $-9.42M | $6.19M | $-27.51M |
Shares Outstanding | 10.07M | 10.07M | 10.07M | 9.92M |